Categories


Taxotere may add misery of permanent hair loss to breast cancer patients’ plight

October 25, 2017 - Some breast cancer survivors have also been left with an enduring, physical reminder of their battle – permanent alopecia – thanks to the cancer drug Taxotere. Read More


First bellwether trial in Cook Medical IVC Filter MDL to begin next week

October 18, 2017 - IVC filters are used to catch blood clots before they reach vital organs such as the heart and lungs. These devices are used when blood thinners are not an option. Read More


Litigation alleges GSK profits off billions in Zofran sales, subjects parents to unnecessary loss

October 11, 2017 - The underlying claim is that Zofran causes birth defects in babies born to women who used the drug while pregnant. Read More


Jury awards $140 million to Plaintiff in testosterone replacement therapy litigation

October 5, 2017 - A jury in Illinois federal court awarded Plaintiff Jeffrey Konrad $140 million in litigation involving testosterone replacement therapy (TRT). Read More


Dietary changes provide better, safer alternative than PPIs in treating acid-related disorders

October 4, 2017 - Dietary intervention may have as much benefit as PPIs in reducing laryngopharyngeal reflux (LPR) – a condition that occurs in a person who has gastroesophageal reflux disease (GERD). Read More


New, contradictory evidence from Xarelto makers could lead to retrial for plaintiff

September 21, 2017 - There is an effective lab test to protect patients taking Xarelto, but that isn’t what jurors heard during last month’s trial against Johnson & Johnson’s Janssen Pharmaceuticals and... Read More


Taxotere MDL trial dates set

September 20, 2017 - Taxotere, a chemotherapy drug approved by the Food and Drug Administration (FDA) to treat breast cancer and other forms of cancer, has been linked to permanent hair loss. Read More


More than 800 Physiomesh incidents filed with FDA report pain, suffering

September 6, 2017 - Since Physiomesh was first approved by the FDA in 2010, medical professionals have reported 839 adverse events, including injuries and at least nine deaths, naming the mesh device as the... Read More


No new trial for Janssen Pharmaceutical in $2.5 million Risperdal case

August 30, 2017 - The company was seeking a new trial as part of an effort to overturn a $2.5 million jury verdict that was awarded in 2015 to an Alabama man Austin Pledger. Read More


Navan Ward appointed to Plaintiffs Executive Committee for PPI litigation

August 25, 2017 - Proton Pump Inhibitor (PPI) drugs have been linked to kidney damage. Read More


back to top